These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 19180157)

  • 1. Vicarious contrast excretion by the gallbladder in contrast nephropathy.
    Umana IE; Dwyer JP
    Kidney Int; 2009 Feb; 75(4):446. PubMed ID: 19180157
    [No Abstract]   [Full Text] [Related]  

  • 2. Vicarious excretion of water-soluble contrast media into the gallbladder in patients with normal serum creatinine.
    Hopper KD; Weingast G; Rudikoff J; Thickman D
    Invest Radiol; 1988 Aug; 23(8):604-8. PubMed ID: 3417438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Iodinated contrast media and nephropathy. Estimated creatinine clearance for better assessment of renal function and dosage].
    Nyman U; Hietala SO; Hellström M; Aspelin P; Björkdahl P; Albrechtsson U; Magnusson A; Måre K; Törnquist C; Ringertz H; Sterner G; Westberg G; Berne C
    Ugeskr Laeger; 2004 Jun; 166(26-31):2566-72. PubMed ID: 15285166
    [No Abstract]   [Full Text] [Related]  

  • 4. [Iodinated contrast media and nephropathy--new recommendations. Estimated creatine clearance for better assessment of renal function and dosage].
    Nyman U; Hietala SO; Hellström M; Aspelin P; Björkdahl P; Albrechtsson U; Magnusson A; Måre K; Törnquist C; Ringertz H; Sterner G; Westberg G; Berne C
    Lakartidningen; 2003 Mar; 100(10):840-3, 846-8. PubMed ID: 12680021
    [No Abstract]   [Full Text] [Related]  

  • 5. Preventing the harm of a closer look: contrast-induced nephropathy in adults.
    Holder MC; Lewis DA; Winstead PS
    Orthopedics; 2012 Apr; 35(4):298-303. PubMed ID: 22495837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Guideline 'Precautionary measures for contrast media containing iodine'].
    van Dijk Azn R; Wetzels JF; ten Dam MA; Aarts NJ; Schimmelpenninck-Scheiffers ML; Freericks MP; Said SA; Geenen RW; Stuurman A; van Everdingen JJ
    Ned Tijdschr Geneeskd; 2008 Mar; 152(13):742-6. PubMed ID: 18461890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An evidence-based approach to minimise contrast-induced nephropathy.
    Darwish T
    N Z Med J; 2009 Jul; 122(1299):39-41. PubMed ID: 19684646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The challenges in assessing contrast-induced nephropathy: where are we now?
    Davenport MS; Cohan RH; Khalatbari S; Ellis JH
    AJR Am J Roentgenol; 2014 Apr; 202(4):784-9. PubMed ID: 24660707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of intravascular contrast media on urinary excretion of liver fatty acid-binding protein].
    Ohta S; Ishimitsu T; Minami J; Ono H; Matsuoka H
    Nihon Jinzo Gakkai Shi; 2005; 47(4):437-44. PubMed ID: 15971886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Role of resuscitation in incidents due to iodine contrast media].
    Testa S
    Minerva Anestesiol; 1974 Apr; 40(4):177-92. PubMed ID: 4830942
    [No Abstract]   [Full Text] [Related]  

  • 11. Lack of correlation between gallbladder opacification in delayed CT and contrast-associated nephropathy.
    Yamazaki H; Oi H; Matsushita M; Kim T; El-Baradie M; Inoue T; Teshima T; Koizumi M; Nose T; Tanaka E; Nakamura H; Inoue T
    Eur Radiol; 1997; 7(8):1328-31. PubMed ID: 9377523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contrast induced nephropathy: an update on diagnosis, predictors, implications and preventive strategies.
    Sholy H; Zukermann R; Soni A; Nikolsky E
    Minerva Med; 2012 Dec; 103(6):465-86. PubMed ID: 23229367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Nephrotoxicity of iodinated contrast products].
    Christin F; Pottecher T
    Ann Fr Anesth Reanim; 2000 Aug; 19(7):fi128-30. PubMed ID: 10976363
    [No Abstract]   [Full Text] [Related]  

  • 14. Contrast media nephropathy--how to diagnose and how to prevent?
    Solomon R
    Nephrol Dial Transplant; 2007 Jul; 22(7):1812-5. PubMed ID: 17449491
    [No Abstract]   [Full Text] [Related]  

  • 15. Contrast associated nephropathy in the elderly.
    Carrillo-Alvira F; Rivera-Bermúdez CG; Jiménez-Velázquez IZ; Ramos-Romey C; González-Concepción JJ
    Bol Asoc Med P R; 2008; 100(3):25-7. PubMed ID: 19227712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-acetylcysteine attenuates iodine contrast agent-induced nephropathy in 5/6-nephrectomized rats.
    Sochman J; Peregrin JH; Bürgelová M; Kopkan L; Kramer HJ; Cervenka L
    Kidney Blood Press Res; 2010; 33(2):149-56. PubMed ID: 20502036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reducing the risk of contrast-induced nephropathy: a perspective on the controversies.
    Ellis JH; Cohan RH
    AJR Am J Roentgenol; 2009 Jun; 192(6):1544-9. PubMed ID: 19457817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study of 2 methods to avoid the nephropathy associated with radiologic contrast].
    Negri AL
    Medicina (B Aires); 1999; 59(6):776. PubMed ID: 10752227
    [No Abstract]   [Full Text] [Related]  

  • 19. Contrast alternatives for iodinated contrast allergy and renal dysfunction: options and limitations.
    Nadolski GJ; Stavropoulos SW
    J Vasc Surg; 2013 Feb; 57(2):593-8. PubMed ID: 23246079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using estimated GFR values to identify patients at risk from iodinated contrast induced nephropathy.
    Adair W; Harris K; Entwisle J
    Clin Radiol; 2006 Aug; 61(8):714-5. PubMed ID: 16843758
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.